These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 7894881

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A prospective study of lithium augmentation in antidepressant-resistant geriatric depression.
    Flint AJ, Rifat SL.
    J Clin Psychopharmacol; 1994 Oct; 14(5):353-6. PubMed ID: 7806693
    [Abstract] [Full Text] [Related]

  • 5. Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study.
    Fava M, Rosenbaum JF, McGrath PJ, Stewart JW, Amsterdam JD, Quitkin FM.
    Am J Psychiatry; 1994 Sep; 151(9):1372-4. PubMed ID: 8067495
    [Abstract] [Full Text] [Related]

  • 6. A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of "vascular depression".
    Taragano FE, Bagnatti P, Allegri RF.
    Int Psychogeriatr; 2005 Sep; 17(3):487-98. PubMed ID: 16252380
    [Abstract] [Full Text] [Related]

  • 7. Capgras syndrome in association with lithium toxicity.
    Canagasabey B, Katona CL.
    Br J Psychiatry; 1991 Dec; 159():879-81. PubMed ID: 1790464
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Platelet 5-HT uptake sites, labelled with [3H] paroxetine, in controls and depressed patients before and after treatment with fluoxetine or lofepramine.
    Lawrence KM, Katona CL, Abou-Saleh MT, Robertson MM, Nairac BL, Edwards DR, Lock T, Burns RA, Harrison DA, Horton RW.
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):261-4. PubMed ID: 7862905
    [Abstract] [Full Text] [Related]

  • 10. Refractory depression: a review with particular reference to the use of lithium augmentation.
    Katona CL.
    Eur Neuropsychopharmacol; 1995 Jun; 5 Suppl():109-13. PubMed ID: 8775769
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Lofepramine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.
    Lancaster SG, Gonzalez JP.
    Drugs; 1989 Feb; 37(2):123-40. PubMed ID: 2649353
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Lithium carbonate augmentation of antidepressant treatment. An effective prescription for treatment-refractory depression.
    Heninger GR, Charney DS, Sternberg DE.
    Arch Gen Psychiatry; 1983 Dec; 40(12):1335-42. PubMed ID: 6418110
    [Abstract] [Full Text] [Related]

  • 16. A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression.
    Joffe RT, Singer W, Levitt AJ, MacDonald C.
    Arch Gen Psychiatry; 1993 May; 50(5):387-93. PubMed ID: 8489327
    [Abstract] [Full Text] [Related]

  • 17. Refractory depression: the addition of lithium to fluoxetine or desipramine.
    Ontiveros A, Fontaine R, Elie R.
    Acta Psychiatr Scand; 1991 Mar; 83(3):188-92. PubMed ID: 1903237
    [Abstract] [Full Text] [Related]

  • 18. The effect of sequential antidepressant treatment on geriatric depression.
    Flint AJ, Rifat SL.
    J Affect Disord; 1996 Jan 22; 36(3-4):95-105. PubMed ID: 8821312
    [Abstract] [Full Text] [Related]

  • 19. Lithium carbonate versus cognitive therapy as sequential combination treatment strategies in partial responders to antidepressant medication: an exploratory trial.
    Kennedy SH, Segal ZV, Cohen NL, Levitan RD, Gemar M, Bagby RM.
    J Clin Psychiatry; 2003 Apr 22; 64(4):439-44. PubMed ID: 12716247
    [Abstract] [Full Text] [Related]

  • 20. Predictors of response to amine-specific antidepressants.
    Burns RA, Lock T, Edwards DR, Katona CL, Harrison DA, Robertson MM, Nairac B, Abou-Saleh MT.
    J Affect Disord; 1995 Dec 13; 35(3):97-106. PubMed ID: 8749837
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.